Advanced Enzyme Technologies Limited
Stock Forecast, Prediction & Price Target
Advanced Enzyme Technologies Limited Financial Estimates
Advanced Enzyme Technologies Limited Revenue Estimates
Advanced Enzyme Technologies Limited EBITDA Estimates
Advanced Enzyme Technologies Limited Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | |||
Revenue
% change YoY
| ₹5.00B N/A | ₹5.28B 5.68% | ₹6.23B 17.88% | Avg: ₹7.88B Low: ₹7.88B High: ₹7.88B avg. 26.51% | |||
Net Income
% change YoY
| ₹1.45B N/A | ₹1.19B -18.05% | ₹1.33B 11.47% | Avg: ₹2.11B Low: ₹2.11B High: ₹2.11B avg. 58.55% | |||
EBITDA
% change YoY
| ₹2.41B N/A | ₹2.07B -14.00% | ₹2.27B 9.42% | Avg: ₹3.17B Low: ₹3.17B High: ₹3.17B avg. 39.59% | |||
EPS
% change YoY
| $13.07 N/A | $10.7 -18.13% | $11.92 11.40% | Avg: $18.9 Low: $18.9 High: $18.9 avg. 58.55% | |||
Operating Expenses
% change YoY
| ₹1.85B N/A | ₹2.40B 30.13% | ₹2.88B 19.89% | Avg: ₹742.20M Low: ₹742.20M High: ₹742.20M avg. -74.30% |
FAQ
What is Advanced Enzyme Technologies Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 58.55% in 2026-2026.
We have gathered data from N/A analysts. Their low estimate is 2.11B, average is 2.11B and high is 2.11B.
What is Advanced Enzyme Technologies Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 26.51% in 2026-2026.
We have gathered data from N/A analysts. Their low revenue estimate is ₹7.88B, average is ₹7.88B and high is ₹7.88B.
What is Advanced Enzyme Technologies Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 58.55% in 2026-2026.
We have gathered data from N/A analysts. Their low earnings per share estimate is $18.9, average is $18.9 and high is ₹18.9.